CRISPR Therapeutics (CRSP) Stock: Buy, Sell, or Hold?
CRSP - CRISPR Therapeutics AG
$51.72
-0.54 (-1.03%)
▼
5d:
-8.44%
30d:
-4.2%
90d:
+2.97%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $55.79 · last confirmed Sep 9, 2026
Strength: 7.2/10
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $51.72, which is considered oversold relative to its 30-day fair value range of $52.62 to $58.23.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $51.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRSP scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $87.56 (+69.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $51.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRSP scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $87.56 (+69.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$52.62 -
$58.23
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.3% below Wall St target ($87.56)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$52.62 -
$58.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$51.62
Resistance Level
$59.37
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.79
Wall Street Target
$87.56
(+69.3%)
Revenue Growth (YoY)
1041.4%
Share & Embed Analysis
Last updated: September 13, 2026 2:07 AM ET
Data refreshes hourly during market hours. Next update: 3:07 AM
Data refreshes hourly during market hours. Next update: 3:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
James R Kasinger
SELL
3182 shares
2026-03-23
Samarth Kulkarni
SELL
10020 shares
2026-03-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$315 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
